PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma

被引：0
|
作者：
Ki Hyung Kim
Kyung Un Choi
Ahrong Kim
So Jung Lee
Jung Hee Lee
Dong Soo Suh
Byung-su Kwon
Chungsu Hwang
机构：
[1] Pusan National University Hospital,Department of Obstetrics and Gynecology
[2] Pusan National University Hospital,Department of Pathology
[3] Pusan National University Yangsan Hospital,Department of Pathology
[4] Research Institute for Convergence of Biomedical Science and Technology,undefined
来源：
Journal of Ovarian Research | / 12卷
关键词：
Ovarian cancer; Tumor-infiltrating lymphocyte; PD-L1; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
    Kim, Ki Hyung
    Choi, Kyung Un
    Kim, Ahrong
    Lee, So Jung
    Lee, Jung Hee
    Suh, Dong Soo
    Kwon, Byung-su
    Hwang, Chungsu
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [2] Correction to: PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma
    Ki Hyung Kim
    Kyung Un Choi
    Ahrong Kim
    So Jung Lee
    Jung Hee Lee
    Dong Soo Suh
    Byung-Su Kwon
    Chungsu Hwang
    Journal of Ovarian Research, 12
  • [3] PD-L1 expression on stromal tumor-infiltrating lymphocytes is a favorable prognostic factor in ovarian serous carcinoma (vol 12, pg 56, 2019)
    Kim, Ki Hyung
    Choi, Kyung Un
    Kim, Ahrong
    Lee, So Jung
    Lee, Jung Hee
    Suh, Dong Soo
    Kwon, Byung-Su
    Hwang, Chungsu
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [4] PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
    Laura Martin de la Fuente
    Sofia Westbom-Fremer
    Nicolai Skovbjerg Arildsen
    Linda Hartman
    Susanne Malander
    Päivi Kannisto
    Anna Måsbäck
    Ingrid Hedenfalk
    Virchows Archiv, 2020, 477 : 83 - 91
  • [5] PD-1/PD-L1 expression and tumor-infiltrating lymphocytes are prognostically favorable in advanced high-grade serous ovarian carcinoma
    de la Fuente, Laura Martin
    Westbom-Fremer, Sofia
    Arildsen, Nicolai Skovbjerg
    Hartman, Linda
    Malander, Susanne
    Kannisto, Paivi
    Masback, Anna
    Hedenfalk, Ingrid
    VIRCHOWS ARCHIV, 2020, 477 (01) : 83 - 91
  • [6] Expression and Prognostic Value of Tumor-Infiltrating Lymphocytes and PD-L1 in Hepatocellular Carcinoma
    Nie, Hanxiao
    He, Tao
    Wang, Li
    Zhang, Ling
    ONCOTARGETS AND THERAPY, 2021, 14 : 1377 - 1385
  • [7] PD-1/PD-L1 EXPRESSION AND TUMOR-INFILTRATING LYMPHOCYTES ARE PROGNOSTICALLY FAVORABLE IN HIGH-GRADE SEROUS OVARIAN CANCER
    de la Fuente, L. Martin
    Fremer, S. Westbom
    Arildsen, N. Skovbjerg
    Hartman, L.
    Malander, S.
    Kannisto, P.
    Masback, A.
    Hedenfalk, I.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 761 - 761
  • [8] PD-L1 Expression in Tumor-Infiltrating Lymphocytes of Invasive Breast Carcinoma
    Hoda, Raza
    Brogi, Edi
    Grabenstetter, Anne
    Patil, Sujata
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge
    Traina, Tiffany
    Robson, Mark
    Norton, Larry
    Wen, Hannah
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 177 - 179
  • [9] PD-L1 Expression in Tumor-Infiltrating Lymphocytes of Invasive Breast Carcinoma
    Hoda, Raza
    Brogi, Edi
    Grabenstetter, Anne
    Patil, Sujata
    Selenica, Pier
    Weigelt, Britta
    Reis-Filho, Jorge
    Traina, Tiffany
    Robson, Mark
    Norton, Larry
    Wen, Hannah
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 177 - 179
  • [10] Prognostic value of tumor-infiltrating lymphocytes and PD-L1 expression in esophageal squamous cell carcinoma
    Hu, Jie
    Toyozumi, Takeshi
    Murakami, Kentaro
    Endo, Satoshi
    Matsumoto, Yasunori
    Otsuka, Ryota
    Shiraishi, Tadashi
    Iida, Shinichiro
    Morishita, Hiroki
    Makiyama, Tenshi
    Nishioka, Yuri
    Uesato, Masaya
    Hayano, Koichi
    Nakano, Akira
    Matsubara, Hisahiro
    CANCER MEDICINE, 2024, 13 (17):
12345